ALKBH3 upregulation has been associated with poorer prognostic outcomes in several cancers, including non-small-cell lung cancer [51], pancreatic cancer [52], renal cell carcinoma [53], and hepatocellular carcinoma [54]. The gene discussed is ALKBH3; the disease is hereditary clear cell renal cell carcinoma.